Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Patent
1991-09-16
1994-04-05
Brust, Joseph Paul
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
562451, 562623, C07C22934, C07C25906
Patent
active
053006747
ABSTRACT:
Compounds of general formula I: ##STR1## Wherein: R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are variables.
These compounds have collagenase inhibition activity and are useful in the management of disease involving collagen degradation. Its uses include rheumatoide arthritis, corneal ulceration, osteoporosis, periodontitis, gingivitis and tumour invasion.
REFERENCES:
patent: 4105789 (1978-08-01), Ondetti et al.
patent: 4496540 (1985-01-01), Kim
patent: 4599361 (1986-07-01), Dickens et al.
Woolley et al., Arthritis and Rheumatism 20 pp. 1231-1239 (1977).
Evans, et al., J. Am. Chem. Soc. 104: pp. 1737-1739 (1982).
Cawston and Barrett, Anal. Biochem. 99: pp. 340-345 (1979).
Cawston and Murphy, Methods in Enzymology 80: pp. 711-722 (1981).
Beckett R. P.
Crimmin M. J.
Davidson A. H.
British Bio-technology Limited
Brust Joseph Paul
LandOfFree
P2'-modified hydroxamic acid collagenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with P2'-modified hydroxamic acid collagenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P2'-modified hydroxamic acid collagenase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-512616